Therapeutic drug monitoring of A77 1726, the active metabolite of leflunomide: serum concentrations predict response to treatment in patients with rheumatoid arthritis

類似資料

• Leflunomide in the treatment of rheumatoid arthritis. An analysis of predictors for treatment continuation
  著者:: van Roon, E N, 等
  出版事項: (2005)
• The active metabolite of leflunomide, A77 1726, interferes with dendritic cell function
  著者:: Kirsch, Bernhard M, 等
  出版事項: (2005)
• Population pharmacokinetics and association between A77 1726 plasma concentrations and disease activity measures following administration of leflunomide to people with rheumatoid arthritis
  著者:: Chan, Vivien, 等
  出版事項: (2005)
• Leflunomide in active rheumatoid arthritis: a prospective study in daily practice
  著者:: Van Roon, E N, 等
  出版事項: (2004)
• Leflunomide in active rheumatoid arthritis: a prospective study in daily practice
  著者:: van Roon, E N, 等
  出版事項: (2004)